ORLEN S.A.: Podsumowanie kosztów emisji akcji wyemitowanych w ramach oferty w związku z połączeniem z Grupą Lotos SA i PGNiG SA (2023-03-24)

Summary of costs related to the issue of shares issued under the public offering in connection with merger of PKN ORLEN and Grupa LOTOS, and merger of PKN ORLEN and PGNiG
Regulatory announcement no 15/2023 dated 24 March 2023

PKN ORLEN S.A. (“Company”) hereby informs about the costs related to the issue of series E shares issued under the public offering in connection with merger of PKN ORLEN and Grupa LOTOS S.A., as well as to the issue of series F shares issued under the public offering in connection with merger of PKN ORLEN and PGNiG S.A.

In connection with the merger of PKN ORLEN and Grupa LOTOS S.A. the Company issued under the public offering 198.738.864 ordinary bearer series E shares "Series E shares". The total costs of the issue of Series E shares amounted to PLN 24,54 m, including:
- costs of preparing and conducting of the public offer of Series E shares: ca. PLN 22,57 m;
- costs of preparing of the document for a prospectus exemption, including consulting costs: ca. PLN 1,97 m;
- costs of promoting of the public offer of Series E shares: PLN 0,00.

The average cost of the public offer per one Series E share amounted to PLN 0,12.

In connection with the merger of PKN ORLEN and PGNiG S.A. the Company issued under the public offering 534.494.124 ordinary bearer series F shares "Series F shares". The total costs of the issue of Series F shares amounted to PLN 27,15 m, including:
- costs of preparing and conducting of the public offer of Series F shares: PLN 25,22 m;
- costs of preparing of the document for a prospectus exemption, including consulting costs: PLN 1,93 m;
- costs of promoting of the public offer of Series F shares: PLN 0,00.

The average cost of the public offer per one Series F share amounted to PLN 0,05.

PKN ORLEN did not incurred the costs of underwriters fees, due to the fact that no underwriting agreement was signed by PKN ORLEN either in connection with the public offer of Series E shares nor the public offer of the Series F shares.

The costs related to the Series E shares and Series F shares issues were included as a decrease of equity within the position of “Share premium”.

See also: regulatory announcement no 45/2022 dated 11 August 2022 and no 80/2022 dated 17 November 2022.